02Dec
UK Life Sciences and Healthcare Newsletter - December 2020: The UK National Security and Investment Bill
The UK has announced a bill proposing a new system to screen transactions for national security risk, separate from the system of merger review operated by the Competition and Markets Authority. The National Security and Investment Bill has been in the pipeline since the publication of the National Security Risk Assessment in 2015, but has been delayed due to Brexit and the COVID-19 pandemic....
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-53811/
Related
In this second edition of October HorrorFest 2020 celebration we consider the first Hammer film vers...
Read More >
Your company has just made its largest acquisition ever and your CEO says that he wants you to have ...
Read More >
On 2 November 2020, Indonesia’s Law on Job Creation went into effect. The Law, amends or revokes o...
Read More >
It is typical in private equity funds for certain tax-sensitive investors, including U.S. tax exempt...
Read More >
In the Matter of Giora Neeman v Town of Warwick, __AD3d__, 2020 NY Slip Op 03112, the Second Departm...
Read More >
Given that the gig economy is a relatively recent phenomenon, the industry has not yet experienced s...
Read More >